BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Polaris 

1000 Winter Street
Suite 3350
Waltham  Massachusetts  02451  U.S.A.
Phone: 781-290-0770 Fax: 781-290-0880


SEARCH JOBS




Industry
Services

Segment
Investments





 Company News
Biotech-Focused VC Firm Polaris Targets $400 Million For 7th Fund 6/26/2014 4:06:57 PM
Shaw T. Chen, M.D., Ph.D. Joins Polaris 4/3/2014 8:27:34 AM
Polaris Announces Positive Results for Phase 2 Study of ADI-PEG 20 in Malignant Pleural Mesothelioma 10/28/2013 7:31:13 AM
Polaris of San Diego to Build $50 Million Facility in Chengdu 3/1/2013 11:16:18 AM
Polaris, Johnson & Johnson (JNJ) Hatch Idea to Solve Drug R&D Crisis: Work Together Early 6/14/2012 8:19:36 AM
Polaris is the Winner of the 2011 Pierre Potier Price Trophy for its Innovation in Chemistry in Favour of Sustainable Development 7/12/2011 9:45:07 AM
Ludwig Institute For Cancer Research (LICR) and Polaris Form Collaboration to Expand Development of Polaris' Novel Cancer Drug, ADI-PEG 20 5/18/2011 9:15:10 AM
Polaris to Highlight Clinical Development Plans for Phase 3-Ready Candidate, ADI-PEG 20, During Symposium in Taiwan 5/12/2011 7:06:14 AM
Polaris Release: Preclinical Studies in Pancreatic Cancer and Melanoma Demonstrated ADI-PEG 20 Works Synergistically With Inhibitors of Autophagy 4/11/2011 8:50:27 AM
Polaris Release: Transcriptional Silencing of ASS1 Suggests the Potential Use of ADI-PEG 20 to Treat AML, Glioblastoma and Bladder Cancer 4/8/2011 7:04:12 AM
12